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However, only poor data are known about safety and efficacy of diltiazem in this setting.
The aim of our study was to evaluate the safety and efficacy of different vasodilators in the
prevention of RAS during transradial PCI.
Methods: 332 patients were consecutively randomized to blindly receive diltiazem 5 mg
(n 117), verapamil 2.5 mg (n109), or isosorbide dinitrate 1 mg (n 106) in three
centers (Paris, France). All study drugs were administrated through the arterial sheath. The
primary end point was the occurrence of a severe RAS defined by the operator as severe
limitation of the catheter movement, with or without angiographic confirmation. Second-
ary endpoints included minor RAS, safety events (need for vasopressor, fluids, atropine
support) and pain assessment scale.
Results: Main characteristics including age, sex, weight, height, diabetes, arterial sheath
diameters, and number of coronary catheters used were identical across the three groups. The
rate of severe RAS was lowest in patients receiving isosorbide dinitrate (n4, 3.8%), and
verapamil (n6, 5.5%), compared to diltiazem (n12, 10.3%) but the difference was not
statistically significant (p0.128). The same results were found for minor RAS, respectively
17.4%, 16.0% and 25.6% (p0.147). There was also no significant difference in term of safety
events and pain sensation between the different groups. PCI was successful for all patients and
no switch to transfemoral was reported in the entire population.
Conclusions: Frequency of severe RAS tended to be higher in patients receiving
diltiazem compared to verapamil and isosorbide dinitrate during transradial procedures.
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Background: The transradial approach for left heart catheterization has become more
frequent due to lower rate of major access site complications Even if the central venous
access from periferal veins is an established technique, less data are available with regard
to its use in the right heart catheterization.
Methods: We analyzed data on 764 patients who underwent left and right heart
catheterizations in our hospital between January 2009 and March 2012.From January
2010 all 4 operators of the Cath-Lab have chosen the radial artery as a standardized
approach for left catheterization and the forearm vein for the right catheterization.
Procedural information, need of access shift, vascular complications, radiological data,
duration of the procedure, type and amount of contrast agent were recorded.
Results: On this population, left and right heart catheterization utilizing the radial artery and
superficial forearm vein were been completed in 325 on 764 patients (45%). 302 (43%)
patients underwent left and right catheterization trough the leg, 106 pts underwent left heart
catheterization through the radial artery and right catheterization trough the femoral vein, 31 pts
underwent left catheterization trough femoral artery and right catheterization trough forearm
vein. From January 2011 the 82% of patients underwent complete cardiac catheterization
trough radial artery and forearm vein. The vein shift from forearm to femoral vein occurred in
14 patients (4%) and the arterial shift from radial to femoral approach in 21 patients (6%). In
the group of right heart catheterization utilizing the superficial forearm vein, complications
related to the vein acces occurred in 1 patients (artero-venouse fistula); in the group of artery
radial access site complications occurred in 2 patients (one artery perforation and one
succlavian artery dissection): no case required surgical treatment.
Conclusions: The transradial artery and superficial forearm venous approach for bilateral
cardiac catheterizations can be safe and feasible alternative to the femoral approach. This
approach can improve safety and patient comfort. Learn and take confidence with this
venous technique can improve the operator’s r.
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Background: Percutaneous approach techniques with closure device after transcutane-
ous aortic valve implantation (TAVI), have diminished vascular complications, which
nevertheless still occur. In this retrospective study we will report incidence and
angiographic factors predisposing to major vascular complications, in patients undergoing
TAVI using Prostar® XL closure device as a default strategy.
Methods: Consecutive patients, who underwent TAVI transfemorally using Prostar® XL,
were evaluated. The incidence of vc was evaluated according to VARC criteria. Using arterial
angiography, the femoral-iliac arterial tortuosity was adjusted for large arterial diameters, and
expressed as the ratio Total Tortuosity/Arterial Diameter (TT/AD). Arterial calcification, the
combination of angulation and atheromatosis at the puncture site, and ideal puncture, were
evaluated too. In all patients, 30 days follow-up was available.
Results: Out of 112 patients treated with TAVI, in 84 patients (42 males (48.8%),
80.25.86 years, AVA: 0.650.14 cm2) the procedure was performed transfemorally. In
patients with major vascular complications (17/84 (20.23%)) comparing to those without,
arterial calcification (11 pts (64.7%) vs. 8 pts (11.9%), p0.01) and the TT/AD (30.2 
11.25 vs. 22.06  8.64, p0.01) were independent predictors. A correlation of the
angiographic TT with the one calculated with computed tomography in 10 selected
patients was verified (r0.66, p0.013). Additionally, ideal puncture was achieved more
frequently among patients without vascular complications comparing to those with major
(94.1% vs. 70.6%, p.0.01). Blood transfusions (1.48  0.37 vs. 2.45  0.59, p0.023)
and procedural delays (5 7.47 minutes vs. 22.71  4.98 minutes, p0.01) were more
frequent among patients with major vascular complications (16/17). Finally, mimimum
creatinine clearance after TAVI predicted all-cause 30 days mortality (p0.021).
Conclusions: Major vascular complications after TAVI with the use of Prostar closure
device can be predicted by arterial calcification at the puncture site and TT/AD ratio.
Minimum creatinine clearance after TAVI, predicted 30-day mortality.
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Background: We conducted a meta-analysis to determine whether transradial catheter-
ization is associated with higher patient radiation exposure compared to transfemoral
access.
Methods: Using various keywords, we conducted search at major electronic databases
from 1950 to May 2012.We included original English language articles comparing
transradial and transfemoral access and reporting patient radiation dose in dose area
product and air kerma. Approximate means and standard deviations were obtained by
assuming that data came from a Weibull distribution derived from Monte-Carlo
algorithm.
Results: A total of 14 studies (3 randomized, 10 prospective, 1 retrospective) were
included for analysis. A meta-analysis of all 14 studies revealed no difference in patient
radiation dose between transradial and transfemoral access (standard difference in
mean0.11, 95% CI 0.04 to 0.25, p 0.15).Analysis of the randomized studies alone
also showed no difference (standard difference in mean 0.079, 95% CI0.025 to 0.183,
p0.14). Figure-1 shows the forest plot of combined and the randomized studies. . The
heterogeneity was high (I squared 94) with all studies combined, however the
heterogeneity decreased after removal of the observational studies (I squared37). This
indicates that most of the heterogeneity came from the observational studies likely a result
of biases inherent to non-randomized studies. Begg and Mazumdar’s correlation test
showed no indication of publication bias (two tailed p 0.36).
Conclusions: Transradial catheterization was not associated with higher patient radiation
exposure than transfemoral access.
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Background: The recent RIVAL trial has made substantial contributions to the world of
percutaneous coronary intervention (PCI), drawing attention to access site and bleeding
complications. However, it is not well known how often the transradial (TR) approach
becomes used after the RIVAL trial in real world clinical practice. We aimed to
TUESDAY, OCTOBER 23, 8:00 AM–10:00 AM www.jacc.tctabstracts2012.com
B118 JACC Vol 60/17/Suppl B | October 22–26, 2012 | TCT Abstracts/POSTER/Vascular Access
P
O
ST
E
R
S
